Faecal markers in the assessment of activity in inflammatory bowel disease
- 3 April 2002
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 16 (4) , 675-681
- https://doi.org/10.1046/j.1365-2036.2002.01196.x
Abstract
The fundamental pathological process behind ulcerative colitis and Crohn's disease is intestinal inflammation. As the precise cause of this is not yet completely understood, current treatment strategies are aimed at reducing or eliminating the inflammation. Endoscopic examination and histological analysis of biopsy specimens remain the `gold standard' methods for detecting and quantifying bowel inflammation; however, these techniques are costly, invasive, and repeated examinations are unpopular with patients. Disease activity questionnaires and laboratory `inflammatory markers', although widely used, show an unreliable correlation with endoscopy and histology. New markers need to be developed to detect and quantify bowel inflammation. These would be of use diagnostically and also an aid to pharmacological treatment.Keywords
This publication has 39 references indexed in Scilit:
- Myeloperoxidase Concentrations in the Stool as a New Parameter of Inflammatory Bowel Disease.The Kurume Medical Journal, 1998
- Investigation of Neutrophils in the Gut Lumen by Assay of Granulocyte Elastase in Whole-Gut Lavage FluidScandinavian Journal of Gastroenterology, 1996
- Clinical investigation of gut immune responsesAdvanced Drug Delivery Reviews, 1995
- Intestinal Protein Loss and Bleeding Assessed by Fecal Hemoglobin, Transferrin, Albumin, and Alpha-1-Antitrypsin Levels in Patients with Colorectal DiseasesDigestion, 1995
- Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel.Gut, 1993
- Fecal Excretion of Radiolabeled (51CrCl3) Proteins in Patients with Crohn's DiseaseScandinavian Journal of Gastroenterology, 1990
- Indium-111-labeled autologous leukocyte imaging and fecal excretionDigestive Diseases and Sciences, 1987
- 111Indium autologous granulocytes in the detection of inflammatory bowel disease.Gut, 1985
- A Comparison of Oral Prednisolone Given as Single or Multiple Daily Doses for Active ProctocolitisScandinavian Journal of Gastroenterology, 1978
- Serum and faecal lysozyme in inflammatory bowel disease.Gut, 1978